wla(warner lambert) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
wla(warner lambert)

An SI Board Since January 1997

Posts	SubjectMarks	Bans	Symbol
942	16	0	WLA

Emcee: trevor john wilkinson	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
142	Peter, The overall market selloff could have caused some profit taking. This n	Ted Downs	-	12/4/1997
141	Downgrade unlikely to be responsible for weakness. Very steady, light volume	cirrus	-	12/4/1997
140	Why the sudden sell off today? Someone must have downgraded. Peter	Peter	-	12/4/1997
139	Linda, From the Lancaster New Era newspaper Dec 2, 1997. Large article on WLA	Ted Downs	-	12/2/1997
138	Linda: Do you have time to talk about WLA? Would be helpful. Won't take u	W. Clinton Terry	-	12/2/1997
137	An upgrade: biz.yahoo.com Linda	Linda Pearson	-	12/2/1997
136	I had no information on European WLA quote, but you must realize that Glaxo'	Zoltan!	-	12/2/1997
135	<On the other hand, Glaxo was trading up in Europe.> Duncan, You forgot	Ted Downs	-	12/2/1997
134	Clinton, Here's an earlier post that summarizes TZDs in the literature as w	Henry Niman	-	12/2/1997
133	From Reuters: <i>Edmund Debler, an analyst at Mehta and Isaly, said the	Zoltan!	-	12/2/1997
132	Linda the gap down and huge volume ..looks way overdone, UNLESS there is someth	Sonki	-	12/2/1997
131	From the same article you cite: >>> The company said it had expect	John Powell	-	12/1/1997
130	I THINK THE PRICE SETBACK WAS OVERDONE AND IS AT MOST TEMPORARY STOCK SHOULD R	DAY TRADER	-	12/1/1997
129	>><i>Need I say more</i> Yes, because those are old figures.	Zoltan!	-	12/1/1997
128	although the cost of liver function monitoring may initialy appear prohibitive,	alexander orlov	-	12/1/1997
127	I do not think or believe that Glaxo tried to undermine <i>troglitazone&l	Zoltan!	-	12/1/1997
126	FWIW, I"m a family doc who has dozens of patients on Rezulin. Mo	Richard Cohen	-	12/1/1997
125	I joined the long club today.......6 diabetic patients dying......not unusual i	Peter	-	12/1/1997
124	Linda, This was a different excerpt from the article: "It strengthened i	George Dawson	-	12/1/1997
123	ALL: Read this... nt.excite.com <The FDA first announced the danger of li	Linda Pearson	-	12/1/1997
122	Peter, <<< Pretty quiet for the big move today! >>> W	Ted Downs	-	12/1/1997
121	RE: "We wonder what their motivation is with respect to the (suspension	Barron Von Hymen	-	12/1/1997
120	Duncan, << Either way, Glaxo stands to be the big winner. >> You	Ted Downs	-	12/1/1997
119	sonki, From Dow Jones... "We expected the revised labeling for Rezulin to	Ted Downs	-	12/1/1997
118	exchange2000.com Regards	Zoltan!	-	12/1/1997

Go to reply# or date (mm/dd/yy):